News

uMotif Announce New Technology Advisor - Dr Alison Vincent, Former Cisco Chief Technology Officer

London, UK - 19 March 2018 - uMotif are pleased to announce the appointment of Dr Alison Vincent to their multi-disciplinary advisory board. Dr Vincent is a technical thought leader with 30 years' experience within global businesses holding senior level positions at Cisco, HSBC, NDS, Micro Focus, and IBM. Together with the uMotif leadership team and fellow advisory board members, Dr Vincent will help shape uMotif's technology strategy.

“We're delighted to further strengthen our advisory board with Alison's experience and depth of technical leadership. As we continue to grow and establish our position in the global eClinical industry Alison will be invaluable in guiding our engineering team to scale the uMotif cloud platform." Said Bruce Hellman, CEO and Co-Founder, uMotif.

While CTO at Cisco UK & Ireland, Dr Vincent was an ambassador and trusted advisor championing Cisco technology to customers, start-ups, governments, partners, press, and analysts. Her previous roles span experience in product management, risk, research and development, strategy execution, and business development, with particular expertise in digital strategy and innovation.

"Since first meeting uMotif, when they won the 2013 Cisco BIG (British Innovation Gateway) Awards, I was struck by their design-led approach. The team is dedicated to building technology that provides the best experience possible for patients. I'm delighted to join their exciting journey as I've seen first-hand how integrated platforms, superbly designed for the user, can really make an impact in global industries." Said Vincent.

Dr Vincent was acknowledged in the Most Influential Women in UK Tech 2017. Frequently published in the press, she is an active blogger and keen social media technical influencer. Dr Vincent holds a PhD in cryptography from London University and a first class honours BSc in maths and computer science. She is also a Fellow of the British Computer Society and a Fellow of the Institute of Engineering and Technology.

About uMotif

uMotif is the leading modern data capture platform for research that patients love to use. With industry expertise in real-world data (RWD) and non-interventional studies the engaging, and clinically-proven, platform captures e-consent, eCOA / ePRO, symptom and wearable device data. Working with top pharmaceutical companies, CROs, and eClinical platforms uMotif can be deployed quickly across the world in any therapeutic area.

Additional information

For media enquiries contact: rachel.lowrey@umotif.com
Connect with uMotif: LinkedIn and Twitter @uMotif
Connect with Dr Alison Vincent: LinkedIn and Twitter @draliv